Literature DB >> 34302031

The characteristics and risk factors of human papillomavirus infection: an outpatient population-based study in Changsha, Hunan.

Dabao Xu1, Xingping Zhao2, Bingsi Gao3, Yu-Ligh Liou4, Yang Yu3, Lingxiao Zou3, Waixing Li3, Huan Huang3, Aiqian Zhang3.   

Abstract

This cross-sectional study investigated the characteristics of cervical HPV infection in Changsha area and explored the influence of Candida vaginitis on this infection. From 11 August 2017 to 11 September 2018, 12,628 outpatient participants ranged from 19 to 84 years old were enrolled and analyzed. HPV DNA was amplified and tested by HPV GenoArray Test Kit. The vaginal ecology was detected by microscopic and biochemistry examinations. The diagnosis of Candida vaginitis was based on microscopic examination (spores, and/or hypha) and biochemical testing (galactosidase) for vaginal discharge by experts. Statistical analyses were performed using SAS 9.4. Continuous and categorical variables were analyzed by t-tests and by Chi-square tests, respectively. HPV infection risk factors were analyzed using multivariate logistic regression. Of the total number of participants, 1753 were infected with HPV (13.88%). Females aged ≥ 40 to < 50 years constituted the largest population of HPV-infected females (31.26%). The top 5 HPV subtypes affecting this population of 1753 infected females were the following: HPV-52 (28.01%), HPV-58 (14.83%), CP8304 (11.47%), HPV-53 (10.84%), and HPV-39 (9.64%). Age (OR 1.01; 95% CI 1-1.01; P < 0.05) and alcohol consumption (OR 1.30; 95% CI 1.09-1.56; P < 0.01) were found to be risk factors for HPV infection. However, the presence of Candida in the vaginal flora was found to be a protective factor against HPV infection (OR 0.62; 95% CI 0.48-0.8; P < 0.001). Comparing with our previous study of 2016, we conclude that the subtype distribution of HPV infection is relatively constant in Changsha. Our data suggest a negative correlation between vaginal Candida and HPV, however, more radical HPV management is required in this area for perimenopausal women and those who regularly consume alcohol.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34302031     DOI: 10.1038/s41598-021-94635-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  50 in total

Review 1.  Human papillomavirus and cancer: the epidemiological evidence.

Authors:  N Muñoz
Journal:  J Clin Virol       Date:  2000-10       Impact factor: 3.168

Review 2.  The distribution and prevalence of human papillomavirus in women in mainland China.

Authors:  Kemin Li; Qingli Li; Liang Song; Danqing Wang; Rutie Yin
Journal:  Cancer       Date:  2019-02-12       Impact factor: 6.860

3.  Detection of oncogenic genital human papillomavirus (HPV) among HPV negative older and younger women after 7 years of follow-up.

Authors:  Kim Agerholm Brogaard; Christian Munk; Thomas Iftner; Kirsten Frederiksen; Susanne K Kjaer
Journal:  J Med Virol       Date:  2014-03-07       Impact factor: 2.327

4.  Risk factors for HPV infection among American Indian and white women in the Northern Plains.

Authors:  Maria C Bell; Delf Schmidt-Grimminger; Clemma Jacobsen; Subhash C Chauhan; Diane M Maher; Dedra S Buchwald
Journal:  Gynecol Oncol       Date:  2011-03-17       Impact factor: 5.482

5.  Incidence of Gardnerella vaginalis, Candida sp and human papilloma virus in cytological smears.

Authors:  E F Murta; M A Souza; E Araújo Júnior; S J Adad
Journal:  Sao Paulo Med J       Date:  2000-07-06       Impact factor: 1.044

6.  Prevalence of and risk factors for high-risk human papillomavirus infection: a population-based study from Hetian, Xinjiang, China.

Authors:  Mayinuer Niyazi; Sulaiya Husaiyin; Lili Han; Huduyum Mamat; Kundus Husaiyin; Lin Wang
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

7.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

8.  Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine.

Authors:  Xuelian Wang; Hannah N Coleman; Uma Nagarajan; Horace J Spencer; Mayumi Nakagawa
Journal:  Vaccine       Date:  2013-10-14       Impact factor: 3.641

9.  Difference in vaginal microecology, local immunity and HPV infection among childbearing-age women with different degrees of cervical lesions in Inner Mongolia.

Authors:  Jing-Jing Zheng; Jing-Hui Song; Cong-Xiang Yu; Fei Wang; Peng-Cheng Wang; Jing-Wei Meng
Journal:  BMC Womens Health       Date:  2019-08-12       Impact factor: 2.809

10.  Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort.

Authors:  Jung Eun Lee; Sunghee Lee; Heetae Lee; Yun-Mi Song; Kayoung Lee; Min Ji Han; Joohon Sung; GwangPyo Ko
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more
  2 in total

1.  Distribution of HPV Subtypes in Diverse Anogenital and Oral Samples from Women and Correlation of Infections with Neoplasia of the Cervix.

Authors:  Karen Bräutigam; Stefanie Meier; Sabina Meneder; Louisa Proppe; Katharina Stroschein; Stephan Polack; Frank Köster; Achim Rody; Sascha Baum
Journal:  Cancers (Basel)       Date:  2022-06-26       Impact factor: 6.575

2.  Feasibility and Accuracy of Menstrual Blood Testing for High-risk Human Papillomavirus Detection With Capture Sequencing.

Authors:  Jingjing Zhang; Xun Tian; Ye Chen; Sisi Huang; Zifeng Cui; Rui Tian; Zhen Zeng; Wenjia Liang; Qifen Gong; Ronghua Shang; Zheng Hu; Chen Cao
Journal:  JAMA Netw Open       Date:  2021-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.